TRIM3 and hepatocellular carcinoma: It has been reported that the mRNA and protein levels of TRIM3 are downregulated in hepatocellular carcinoma (HCC) and are correlated with an unfavorable prognosis in patients with HCC, suggesting that TRIM3 could be a prognostic marker and novel therapeutic target for HCC [35].